Skip to main content
Top
Published in: Drugs & Aging 7/2023

Open Access 09-05-2023 | Opioids | Original Research Article

Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study

Authors: Kenji Fujita, Patrick Hooper, Nashwa Masnoon, Sarita Lo, Danijela Gnjidic, Christopher Etherton-Beer, Emily Reeve, Parker Magin, J. Simon Bell, Kenneth Rockwood, Lisa Kouladjian O’Donnell, Mouna Sawan, Melissa Baysari, Sarah N. Hilmer

Published in: Drugs & Aging | Issue 7/2023

Login to get access

Abstract

Introduction

Implementation of the Drug Burden Index (DBI) as a risk assessment tool in clinical practice may facilitate deprescribing.

Objective

The purpose of this study is to evaluate how a comprehensive intervention bundle using the DBI impacts (i) the proportion of older inpatients with at least one DBI-contributing medication stopped or dose reduced on discharge, compared with admission; and (ii) the changes in deprescribing of different DBI-contributing medication classes during hospitalisation.

Methods

This before-and-after study was conducted in an Australian metropolitan tertiary referral hospital. Patients aged ≥ 75 years admitted to the acute aged care service for ≥ 48 h from December 2020 to October 2021 and prescribed DBI-contributing medication were included. During the control period, usual care was provided. During the intervention, access to the intervention bundle was added, including a clinician interface displaying DBI score in the electronic medical record. In a subsequent ‘stewardship’ period, a stewardship pharmacist used the bundle to provide clinicians with patient-specific recommendations on deprescribing of DBI-contributing medications.

Results

Overall, 457 hospitalisations were included. The proportion of patients with at least one DBI-contributing medication stopped/reduced on discharge increased from 29.9% (control period) to 37.5% [intervention; adjusted risk difference (aRD) 6.5%, 95% confidence intervals (CI) −3.2 to 17.5%] and 43.1% (stewardship; aRD 12.1%, 95% CI 1.0–24.0%). The proportion of opioid prescriptions stopped/reduced rose from 17.9% during control to 45.7% during stewardship (p = 0.04).

Conclusion

Integrating a comprehensive intervention bundle and accompanying stewardship program is a promising strategy to facilitate deprescribing of sedative and anticholinergic medications in older inpatients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkinson L, Magin PJ, Thomson A, Byles JE, Caughey GE, Etherton-Beer C, et al. Anticholinergic burden in older women: not seeing the wood for the trees? Med J Aust. 2015;202(2):91–4.PubMed Parkinson L, Magin PJ, Thomson A, Byles JE, Caughey GE, Etherton-Beer C, et al. Anticholinergic burden in older women: not seeing the wood for the trees? Med J Aust. 2015;202(2):91–4.PubMed
2.
go back to reference Malagaris I, Mehta HB, Li S, Goodwin JS. Decrease of anticholinergic drug use in nursing home residents in the United States, 2009 to 2017. J Am Geriatr Soc (JAGS). 2020;68(12):2797–804. Malagaris I, Mehta HB, Li S, Goodwin JS. Decrease of anticholinergic drug use in nursing home residents in the United States, 2009 to 2017. J Am Geriatr Soc (JAGS). 2020;68(12):2797–804.
3.
go back to reference Herrero-Zazo M, Berry R, Bines E, Bhattacharya D, Myint PK, Keevil VL. Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes. Ther Adv Drug Saf. 2021;12:20420986211012590.PubMedPubMedCentral Herrero-Zazo M, Berry R, Bines E, Bhattacharya D, Myint PK, Keevil VL. Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes. Ther Adv Drug Saf. 2021;12:20420986211012590.PubMedPubMedCentral
4.
go back to reference Bell J, Mezrani C, Blacker N, LeBlanc T, Frank O, Alderman CP, et al. Anticholinergic and sedative medicines: prescribing considerations for people with dementia. Aust Fam Physician. 2012;41(1/2):45–9.PubMed Bell J, Mezrani C, Blacker N, LeBlanc T, Frank O, Alderman CP, et al. Anticholinergic and sedative medicines: prescribing considerations for people with dementia. Aust Fam Physician. 2012;41(1/2):45–9.PubMed
5.
go back to reference Hilmer S, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8.PubMed Hilmer S, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–8.PubMed
6.
go back to reference Hilmer SN, Wu H, Zhang M. Biology of frailty: implications for clinical pharmacology and drug therapy in frail older people. Mech Ageing Dev. 2019;181:22–8.PubMed Hilmer SN, Wu H, Zhang M. Biology of frailty: implications for clinical pharmacology and drug therapy in frail older people. Mech Ageing Dev. 2019;181:22–8.PubMed
7.
go back to reference Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing: ATTITUDES TOWARD DEPRESCRIBING. J Am Geriatr Soc (JAGS). 2019;67(6):1204–10. Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing: ATTITUDES TOWARD DEPRESCRIBING. J Am Geriatr Soc (JAGS). 2019;67(6):1204–10.
8.
go back to reference Wu H, Kouladjian O’Donnell L, Fujita K, Masnoon N, Hilmer SN. Deprescribing in the older patient: a narrative review of challenges and solutions. Int J Gen Med. 2021;14:3793–807.PubMedPubMedCentral Wu H, Kouladjian O’Donnell L, Fujita K, Masnoon N, Hilmer SN. Deprescribing in the older patient: a narrative review of challenges and solutions. Int J Gen Med. 2021;14:3793–807.PubMedPubMedCentral
9.
go back to reference Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.PubMedPubMedCentral Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.PubMedPubMedCentral
10.
go back to reference Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A Drug Burden Index to define the functional burden of medications in older people. Arch Intern Med (1960). 2007;167(8):781–7. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A Drug Burden Index to define the functional burden of medications in older people. Arch Intern Med (1960). 2007;167(8):781–7.
11.
go back to reference Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN. Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503–15.PubMedPubMedCentral Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN. Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503–15.PubMedPubMedCentral
12.
go back to reference Hilmer SNMDP, Mager DEPP, Simonsick EMP, Ling SMMD, Windham BGMD, Harris TBMDMS, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142–9.e2. Hilmer SNMDP, Mager DEPP, Simonsick EMP, Ling SMMD, Windham BGMD, Harris TBMDMS, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142–9.e2.
13.
go back to reference Gnjidic D, Cumming RG, Le Couteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68(1):97–105.PubMedPubMedCentral Gnjidic D, Cumming RG, Le Couteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68(1):97–105.PubMedPubMedCentral
14.
go back to reference Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Cumming RG, Handelsman DJ, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–8.PubMed Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Cumming RG, Handelsman DJ, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–8.PubMed
15.
go back to reference Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, et al. Effects of Drug Burden Index on cognitive function in older men. J Clin Psychopharmacol. 2012;32(2):273–7.PubMed Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, et al. Effects of Drug Burden Index on cognitive function in older men. J Clin Psychopharmacol. 2012;32(2):273–7.PubMed
16.
go back to reference Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between Drug Burden Index and falls in older people in residential aged care. J Am Geriatr Soc (JAGS). 2011;59(5):875–80. Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between Drug Burden Index and falls in older people in residential aged care. J Am Geriatr Soc (JAGS). 2011;59(5):875–80.
17.
go back to reference Kouladjian O’Donnell L, Gnjidic D, Chen TF, Hilmer SN. Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications. Ther Adv Drug Saf. 2019;10:2042098619832471.PubMedPubMedCentral Kouladjian O’Donnell L, Gnjidic D, Chen TF, Hilmer SN. Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications. Ther Adv Drug Saf. 2019;10:2042098619832471.PubMedPubMedCentral
18.
go back to reference Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;2018(9):CD008165.PubMedCentral Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;2018(9):CD008165.PubMedCentral
19.
go back to reference Gillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, Rège-Walther M, et al. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013;2013(11):CD002894. Gillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, Rège-Walther M, et al. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013;2013(11):CD002894.
20.
go back to reference Baysari MT, Duong MH, Hooper P, Stockey-Bridge M, Awad S, Zheng WY, et al. Supporting deprescribing in hospitalised patients: formative usability testing of a computerised decision support tool. BMC Med Inform Decis Mak. 2021;21(1):116.PubMedPubMedCentral Baysari MT, Duong MH, Hooper P, Stockey-Bridge M, Awad S, Zheng WY, et al. Supporting deprescribing in hospitalised patients: formative usability testing of a computerised decision support tool. BMC Med Inform Decis Mak. 2021;21(1):116.PubMedPubMedCentral
21.
go back to reference Sawan M, O’Donnell LK, Reeve E, Gnjidic D, Chen TF, Kelly PJ, et al. The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Res Soc Adm Pharm. 2021;17(4):715–22. Sawan M, O’Donnell LK, Reeve E, Gnjidic D, Chen TF, Kelly PJ, et al. The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Res Soc Adm Pharm. 2021;17(4):715–22.
22.
go back to reference Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233–45.PubMedPubMedCentral Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233–45.PubMedPubMedCentral
23.
go back to reference Masnoon N, Lo S, Hilmer S. A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records. Br J Clin Pharmacol. 2023;89(2):687–98.PubMed Masnoon N, Lo S, Hilmer S. A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records. Br J Clin Pharmacol. 2023;89(2):687–98.PubMed
24.
go back to reference Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239.PubMedPubMedCentral Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239.PubMedPubMedCentral
25.
go back to reference Gnjidic D, Bell JS, Hilmer SN, Lönnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (Helsinki). 2012;44(5):458–67. Gnjidic D, Bell JS, Hilmer SN, Lönnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (Helsinki). 2012;44(5):458–67.
26.
go back to reference Duong MH, McLachlan AJ, Bennett AA, Jokanovic N, Le Couteur DG, Baysari MT, et al. Iterative development of clinician guides to support deprescribing decisions and communication for older patients in hospital: a novel methodology. Drugs Aging. 2020;38(1):75–87.PubMed Duong MH, McLachlan AJ, Bennett AA, Jokanovic N, Le Couteur DG, Baysari MT, et al. Iterative development of clinician guides to support deprescribing decisions and communication for older patients in hospital: a novel methodology. Drugs Aging. 2020;38(1):75–87.PubMed
27.
go back to reference Jokanovic N, Aslani P, Carter S, Duong M, Gnjidic D, Jansen J, et al. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study. BMJ Open. 2019;9(12): e033303.PubMedPubMedCentral Jokanovic N, Aslani P, Carter S, Duong M, Gnjidic D, Jansen J, et al. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study. BMJ Open. 2019;9(12): e033303.PubMedPubMedCentral
28.
go back to reference Ng B, Duong M, Lo S, Le Couteur D, Hilmer S. Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Res Soc Adm Pharm. 2021;17(11):1997–2005. Ng B, Duong M, Lo S, Le Couteur D, Hilmer S. Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Res Soc Adm Pharm. 2021;17(11):1997–2005.
30.
go back to reference Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171(5):618–23.PubMed Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171(5):618–23.PubMed
31.
go back to reference Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1(1):54–75. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1(1):54–75.
32.
go back to reference Grembi JA, Rogawski McQuade ET. Introducing riskCommunicator: an R package to obtain interpretable effect estimates for public health. PLoS ONE. 2022;17(7): e0265368.PubMedPubMedCentral Grembi JA, Rogawski McQuade ET. Introducing riskCommunicator: an R package to obtain interpretable effect estimates for public health. PLoS ONE. 2022;17(7): e0265368.PubMedPubMedCentral
33.
go back to reference Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, et al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ (Online). 2013;346(1):88–657. Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, et al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ (Online). 2013;346(1):88–657.
34.
go back to reference Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of home medicines review. Drugs Aging. 2010;27(2):135–48.PubMed Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of home medicines review. Drugs Aging. 2010;27(2):135–48.PubMed
35.
go back to reference Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677–86.PubMed Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677–86.PubMed
36.
go back to reference Gnjidic D, Couteur DGL, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44(11):1725–32.PubMed Gnjidic D, Couteur DGL, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44(11):1725–32.PubMed
37.
go back to reference Best O, Gnjidic D, Hilmer SN, Naganathan V, McLachlan AJ. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J. 2013;43(8):912–8.PubMed Best O, Gnjidic D, Hilmer SN, Naganathan V, McLachlan AJ. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J. 2013;43(8):912–8.PubMed
38.
go back to reference Lönnroos E, Gnjidic D, Hilmer SN, Bell JS, Kautiainen H, Sulkava R, et al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging. 2012;29(5):395–404.PubMed Lönnroos E, Gnjidic D, Hilmer SN, Bell JS, Kautiainen H, Sulkava R, et al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging. 2012;29(5):395–404.PubMed
39.
go back to reference Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug Burden Index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584–91.PubMed Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug Burden Index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584–91.PubMed
40.
go back to reference Kashyap M, Belleville S, Mulsant BH, Hilmer SN, Paquette A, Tu LM, et al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (JAGS). 2014;62(2):336–41. Kashyap M, Belleville S, Mulsant BH, Hilmer SN, Paquette A, Tu LM, et al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (JAGS). 2014;62(2):336–41.
41.
go back to reference Narayan SW, Hilmer SN, Horsburgh S, Nishtala PS. Anticholinergic component of the Drug Burden Index and the anticholinergic drug scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging. 2013;30(11):927–34.PubMed Narayan SW, Hilmer SN, Horsburgh S, Nishtala PS. Anticholinergic component of the Drug Burden Index and the anticholinergic drug scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging. 2013;30(11):927–34.PubMed
42.
go back to reference Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753–8.PubMed Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753–8.PubMed
43.
go back to reference Lalic S, Ilomäki J, Bell JS, Korhonen MJ, Gisev N. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2019;85(1):202–15.PubMed Lalic S, Ilomäki J, Bell JS, Korhonen MJ, Gisev N. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2019;85(1):202–15.PubMed
44.
go back to reference Holliday S, Morgan S, Tapley A, Dunlop A, Henderson K, van Driel M, et al. The pattern of opioid management by Australian general practice trainees. Pain Med (Malden, Mass). 2015;16(9):1720–31. Holliday S, Morgan S, Tapley A, Dunlop A, Henderson K, van Driel M, et al. The pattern of opioid management by Australian general practice trainees. Pain Med (Malden, Mass). 2015;16(9):1720–31.
45.
go back to reference Langford AV, Gnjidic D, Lin C-WC, Bero L, Penm J, Blyth FM, et al. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133–40.PubMed Langford AV, Gnjidic D, Lin C-WC, Bero L, Penm J, Blyth FM, et al. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133–40.PubMed
46.
go back to reference Roshanov PS, Misra S, Gerstein HC, Garg AX, Sebaldt RJ, Mackay JA, et al. Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review. Implement Sci. 2011;6(1):92.PubMedPubMedCentral Roshanov PS, Misra S, Gerstein HC, Garg AX, Sebaldt RJ, Mackay JA, et al. Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review. Implement Sci. 2011;6(1):92.PubMedPubMedCentral
47.
go back to reference Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ (Online). 2020;370:m3216.PubMed Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ (Online). 2020;370:m3216.PubMed
48.
go back to reference Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11):e15385.PubMedPubMedCentral Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11):e15385.PubMedPubMedCentral
49.
go back to reference Scott IA, Reeve E, Hilmer SN. Establishing the worth of deprescribing inappropriate medications: are we there yet? Med J Aust. 2022;217(6):283–6.PubMedPubMedCentral Scott IA, Reeve E, Hilmer SN. Establishing the worth of deprescribing inappropriate medications: are we there yet? Med J Aust. 2022;217(6):283–6.PubMedPubMedCentral
50.
go back to reference McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval É, Atique A, et al. The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial. JAMA Intern Med. 2022;182(3):265–73.PubMed McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval É, Atique A, et al. The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial. JAMA Intern Med. 2022;182(3):265–73.PubMed
Metadata
Title
Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study
Authors
Kenji Fujita
Patrick Hooper
Nashwa Masnoon
Sarita Lo
Danijela Gnjidic
Christopher Etherton-Beer
Emily Reeve
Parker Magin
J. Simon Bell
Kenneth Rockwood
Lisa Kouladjian O’Donnell
Mouna Sawan
Melissa Baysari
Sarah N. Hilmer
Publication date
09-05-2023
Publisher
Springer International Publishing
Keywords
Opioids
Opioids
Published in
Drugs & Aging / Issue 7/2023
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-023-01032-6

Other articles of this Issue 7/2023

Drugs & Aging 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.